Prevention of heterotopic ossification after total hip replacement: a prospective comparison of indomethacin and salmon calcitonin in 60 patients
This 2001 prospective study compared the efficacy of indomethacin (100 mg/day) and salmon calcitonin (3 MRC-U/kg/day) administered for 14 days in preventing heterotopic ossification (HO) following total hip replacement. Among 60 patients (30 per group), 19 in the indomethacin group and 2 in the calcitonin group developed HO. The findings
June 26, 2025
No Comments